Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFS |
Texto Completo: | https://ri.ufs.br/jspui/handle/riufs/15603 |
Resumo: | Introduction: Sickle cell anemia is a genetic disease responsible for the production of hemoglobin S, with a wide variety of clinical presentations. One of the most widespread therapies for its treatment is hemotransfusion, which although it offers clinical benefit, is not free of complications, like alloimmunization. The presence of auto and alloantibodies is a relevant factor in the selection and availability of blood products for treatment. The relationship between the presence of alloimmunization and the clinical and laboratory manifestations of this disease is little studied in the literature and the objective of the present study is to evaluate the frequency of antibodies and the relationship between alloimmunization and clinical and laboratory abnormalities in sickle cell anemia. Methods: This is a historical cohort study, in which the medical records of patients with sickle cell anemia at the pediatric hematology outpatient clinic of the University Hospital of the Federal University of Sergipe were reviewed. Patients were phenotyped as a pre-transfusion routine at the local hemocenter. The mean of the last five laboratory tests and the frequency of various clinical complications were compared between alloimmunized and non-alloimmunized patients. Results: The prevalence of alloimmunized patients in the study was 19.6% with 12 types of alloantibodies found. There was an association between older age and higher number of transfusions and use of hydroxyurea with alloimmunization, since neonatal screening was not protective. The presence of irregular antibodies was directly related to the presence of autoantibodies and to higher values of mean corpuscular volume (MCV). The other clinical variables were not significantly influenced by alloimmunization |
id |
UFS-2_c7647daf7d57bed506ab0af817bc36d1 |
---|---|
oai_identifier_str |
oai:ufs.br:riufs/15603 |
network_acronym_str |
UFS-2 |
network_name_str |
Repositório Institucional da UFS |
repository_id_str |
|
spelling |
Souza, Ricardo Henrique LealMenezes Neto, Osvaldo Alves de2022-05-03T14:58:52Z2022-05-03T14:58:52Z2019-02-27Souza, Ricardo Henrique Leal. Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme. 2019. 56 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019.https://ri.ufs.br/jspui/handle/riufs/15603Introduction: Sickle cell anemia is a genetic disease responsible for the production of hemoglobin S, with a wide variety of clinical presentations. One of the most widespread therapies for its treatment is hemotransfusion, which although it offers clinical benefit, is not free of complications, like alloimmunization. The presence of auto and alloantibodies is a relevant factor in the selection and availability of blood products for treatment. The relationship between the presence of alloimmunization and the clinical and laboratory manifestations of this disease is little studied in the literature and the objective of the present study is to evaluate the frequency of antibodies and the relationship between alloimmunization and clinical and laboratory abnormalities in sickle cell anemia. Methods: This is a historical cohort study, in which the medical records of patients with sickle cell anemia at the pediatric hematology outpatient clinic of the University Hospital of the Federal University of Sergipe were reviewed. Patients were phenotyped as a pre-transfusion routine at the local hemocenter. The mean of the last five laboratory tests and the frequency of various clinical complications were compared between alloimmunized and non-alloimmunized patients. Results: The prevalence of alloimmunized patients in the study was 19.6% with 12 types of alloantibodies found. There was an association between older age and higher number of transfusions and use of hydroxyurea with alloimmunization, since neonatal screening was not protective. The presence of irregular antibodies was directly related to the presence of autoantibodies and to higher values of mean corpuscular volume (MCV). The other clinical variables were not significantly influenced by alloimmunizationIntrodução: A anemia falciforme é uma doença genética responsável pela produção da hemoglobina S, possuindo uma grande variedade de apresentações clínicas. Uma das terapêuticas mais difundidas para o seu tratamento é a hemotransfusão, que embora ofereça beneficio clínico, não é isenta de complicações, a exemplo da aloimunização. A presença de auto e aloanticorpos é fator relevante na triagem e na disponibilidade de hemoderivados para o tratamento. A relação entre a presença de aloimunização e as manifestações clínicas e laboratoriais dessa doença é pouco estudada na literatura e o objetivo do presente estudo é avaliar a frequência de anticorpos e a relação entre a aloimunização e as alterações clínicas e laboratoriais na anemia falciforme. Métodos: Esse é um estudo de coorte histórica, onde foram revisados os prontuários dos pacientes portadores de anemia falciforme do ambulatório de hematologia pediátrica do Hospital Universitário da Universidade Federal de Sergipe. Os pacientes foram fenotipados como rotina pré-transfusional no hemocentro local. A média dos cinco últimos exames laboratoriais e a frequência de várias complicações clínicas foram comparadas entre aloimunizados e não aloimunizados. Resultados: A prevalência de pacientes aloimunizados no estudo foi de 19,6% com 12 tipos de aloanticorpos encontrados. Houve associação entre maior idade e maior número de transfusões e uso de hidroxiureia com a aloimunização, já a triagem neonatal não se mostrou protetora. A presença de anticorpos irregulares teve relação direta com a presença de autoanticorpos e com valores maiores de volume corpuscular médio (VCM). As demais variáveis clínicas não sofreram influência significativa da aloimunizaçãoAracajuporAnemia falciformeAnticorposEvolução clínicaSickle cell anemiaAntibodiesClinical courseCIENCIAS DA SAUDE::MEDICINAAvaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciformeinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal de SergipeDME - Departamento de Medicina – Aracaju - Presencialreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSinfo:eu-repo/semantics/openAccessORIGINALRicardo_Henrique_Leal_Souza.pdfRicardo_Henrique_Leal_Souza.pdfapplication/pdf569072https://ri.ufs.br/jspui/bitstream/riufs/15603/2/Ricardo_Henrique_Leal_Souza.pdfaa9b3b57b2de4cb223ec860878ed7e19MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81475https://ri.ufs.br/jspui/bitstream/riufs/15603/1/license.txt098cbbf65c2c15e1fb2e49c5d306a44cMD51TEXTRicardo_Henrique_Leal_Souza.pdf.txtRicardo_Henrique_Leal_Souza.pdf.txtExtracted texttext/plain88585https://ri.ufs.br/jspui/bitstream/riufs/15603/3/Ricardo_Henrique_Leal_Souza.pdf.txt695a18a723eaf089a0092150c630de6fMD53THUMBNAILRicardo_Henrique_Leal_Souza.pdf.jpgRicardo_Henrique_Leal_Souza.pdf.jpgGenerated Thumbnailimage/jpeg1289https://ri.ufs.br/jspui/bitstream/riufs/15603/4/Ricardo_Henrique_Leal_Souza.pdf.jpg395ac440e11f7c58c0e960cc13c5fc5dMD54riufs/156032022-05-03 12:01:20.698oai:ufs.br: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Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2022-05-03T15:01:20Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false |
dc.title.pt_BR.fl_str_mv |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
title |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
spellingShingle |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme Souza, Ricardo Henrique Leal Anemia falciforme Anticorpos Evolução clínica Sickle cell anemia Antibodies Clinical course CIENCIAS DA SAUDE::MEDICINA |
title_short |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
title_full |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
title_fullStr |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
title_full_unstemmed |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
title_sort |
Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme |
author |
Souza, Ricardo Henrique Leal |
author_facet |
Souza, Ricardo Henrique Leal |
author_role |
author |
dc.contributor.author.fl_str_mv |
Souza, Ricardo Henrique Leal |
dc.contributor.advisor1.fl_str_mv |
Menezes Neto, Osvaldo Alves de |
contributor_str_mv |
Menezes Neto, Osvaldo Alves de |
dc.subject.por.fl_str_mv |
Anemia falciforme Anticorpos Evolução clínica |
topic |
Anemia falciforme Anticorpos Evolução clínica Sickle cell anemia Antibodies Clinical course CIENCIAS DA SAUDE::MEDICINA |
dc.subject.eng.fl_str_mv |
Sickle cell anemia Antibodies Clinical course |
dc.subject.cnpq.fl_str_mv |
CIENCIAS DA SAUDE::MEDICINA |
description |
Introduction: Sickle cell anemia is a genetic disease responsible for the production of hemoglobin S, with a wide variety of clinical presentations. One of the most widespread therapies for its treatment is hemotransfusion, which although it offers clinical benefit, is not free of complications, like alloimmunization. The presence of auto and alloantibodies is a relevant factor in the selection and availability of blood products for treatment. The relationship between the presence of alloimmunization and the clinical and laboratory manifestations of this disease is little studied in the literature and the objective of the present study is to evaluate the frequency of antibodies and the relationship between alloimmunization and clinical and laboratory abnormalities in sickle cell anemia. Methods: This is a historical cohort study, in which the medical records of patients with sickle cell anemia at the pediatric hematology outpatient clinic of the University Hospital of the Federal University of Sergipe were reviewed. Patients were phenotyped as a pre-transfusion routine at the local hemocenter. The mean of the last five laboratory tests and the frequency of various clinical complications were compared between alloimmunized and non-alloimmunized patients. Results: The prevalence of alloimmunized patients in the study was 19.6% with 12 types of alloantibodies found. There was an association between older age and higher number of transfusions and use of hydroxyurea with alloimmunization, since neonatal screening was not protective. The presence of irregular antibodies was directly related to the presence of autoantibodies and to higher values of mean corpuscular volume (MCV). The other clinical variables were not significantly influenced by alloimmunization |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019-02-27 |
dc.date.accessioned.fl_str_mv |
2022-05-03T14:58:52Z |
dc.date.available.fl_str_mv |
2022-05-03T14:58:52Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
Souza, Ricardo Henrique Leal. Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme. 2019. 56 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019. |
dc.identifier.uri.fl_str_mv |
https://ri.ufs.br/jspui/handle/riufs/15603 |
identifier_str_mv |
Souza, Ricardo Henrique Leal. Avaliação imunohematológica e influência da aloimunização eritrocitária na evolução clínica dos pacientes com anemia falciforme. 2019. 56 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019. |
url |
https://ri.ufs.br/jspui/handle/riufs/15603 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.initials.fl_str_mv |
Universidade Federal de Sergipe |
dc.publisher.department.fl_str_mv |
DME - Departamento de Medicina – Aracaju - Presencial |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFS instname:Universidade Federal de Sergipe (UFS) instacron:UFS |
instname_str |
Universidade Federal de Sergipe (UFS) |
instacron_str |
UFS |
institution |
UFS |
reponame_str |
Repositório Institucional da UFS |
collection |
Repositório Institucional da UFS |
bitstream.url.fl_str_mv |
https://ri.ufs.br/jspui/bitstream/riufs/15603/2/Ricardo_Henrique_Leal_Souza.pdf https://ri.ufs.br/jspui/bitstream/riufs/15603/1/license.txt https://ri.ufs.br/jspui/bitstream/riufs/15603/3/Ricardo_Henrique_Leal_Souza.pdf.txt https://ri.ufs.br/jspui/bitstream/riufs/15603/4/Ricardo_Henrique_Leal_Souza.pdf.jpg |
bitstream.checksum.fl_str_mv |
aa9b3b57b2de4cb223ec860878ed7e19 098cbbf65c2c15e1fb2e49c5d306a44c 695a18a723eaf089a0092150c630de6f 395ac440e11f7c58c0e960cc13c5fc5d |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS) |
repository.mail.fl_str_mv |
repositorio@academico.ufs.br |
_version_ |
1802110738526896128 |